MyoStrain

MyoStrain Myocardial Solutions' mission is to transform cardiology and cancer care towards heart failure preve

Happy Holidays from our team to yours!As we head into the season of celebration, we hope you find time to rest, recharge...
12/25/2025

Happy Holidays from our team to yours!
As we head into the season of celebration, we hope you find time to rest, recharge, and take care of your well-being. May your holidays be full of joy, good health, and moments that bring you peace.

The following PREFECT study reveals Fast-SENC (MyoStrain) as a breakthrough in early detection of subclinical cardiotoxi...
12/22/2025

The following PREFECT study reveals Fast-SENC (MyoStrain) as a breakthrough in early detection of subclinical cardiotoxicity: https://bit.ly/3RpkRfJ

The results of the study show that out of 63 patients, 41% experienced subclinical cardiotoxicity. Fast-SENC (MyoStrain) effectively detected subclinical cardiotoxicity and clinical cardiotoxicity.

Elevate your standards with MyoStrain’s cutting-edge technology. Learn more about MyoStrain by visiting our website: https://bit.ly/46VFerp

Precision matters in cardiac care. MyoStrain technology equips physicians with the tools to help proactively identify pa...
12/15/2025

Precision matters in cardiac care. MyoStrain technology equips physicians with the tools to help proactively identify patients who can benefit from cardioprotective therapy before cardiotoxicity strikes. Elevate your clinical practice with MyoStrain. Hear more from physicians who have worked with MyoStrain by visiting the following page: https://bit.ly/48vYm2I

Wishing everyone a warm and happy Thanksgiving! We’re grateful for our community, our partners, and the opportunity to s...
11/27/2025

Wishing everyone a warm and happy Thanksgiving! We’re grateful for our community, our partners, and the opportunity to support the work we do every day. Enjoy a safe and restful holiday with family and friends.

Breast Cancer Awareness Month reminds us that survivorship means more than beating cancer, it also means protecting long...
10/15/2025

Breast Cancer Awareness Month reminds us that survivorship means more than beating cancer, it also means protecting long-term heart health.
A 2-year longitudinal study demonstrated that MyoStrain® (fast-SENC CMR) provided the most accurate and sensitive measure for detecting and predicting cardiotoxicity in patients undergoing chemotherapy. In fact, MyoStrain detected cardiotoxicity with 96% accuracy, outperforming LVEF, T1, T2 mapping, and biomarkers.
Early detection enables cardiologists and oncologists to act sooner, guide therapy, and improve recovery outcomes.
Read more: https://bit.ly/48ePPkS

10/14/2025

Twenty years ago, the discovery of a biomarker forever changed the outlook for lung cancer patients.

It taught us a powerful lesson: the earlier we detect, the more lives we save.

Today, in cardiology, that same philosophy takes shape with MyoStrain®, a quick, non-invasive test that allows us to see what the clinical eye can’t yet perceive —
the first signs of cardiac muscle dysfunction, even when ejection fraction appears normal.

For oncology patients, MyoStrain is making a real difference, identifying cardiac damage before chemotherapy leaves irreversible effects.

💡 Early detection saves hearts, just as it once saved lungs.

And that is — once again — a silent revolution in medicine.

This Breast Cancer Awareness Month, we celebrate patients and survivors—and recognize the importance of caring for the h...
10/06/2025

This Breast Cancer Awareness Month, we celebrate patients and survivors—and recognize the importance of caring for the heart throughout cancer treatment.
Nearly 1 in 3 patients on anti-HER2 breast cancer therapy may face heart complications. That’s where innovations like MyoStrain® make a difference, giving doctors the ability to detect heart changes early and keep patients safe while they fight cancer.
Read more in The Role of Advanced Cardiovascular Imaging Modalities in Cardio-Oncology: https://bit.ly/3VM5MaJ

Today on World Heart Day, we recognize the importance of early detection in protecting heart health worldwide.Cardiac di...
09/29/2025

Today on World Heart Day, we recognize the importance of early detection in protecting heart health worldwide.
Cardiac disease remains the leading cause of death globally, yet many conditions can be prevented or better managed when detected early. That’s where MyoStrain® plays a key role—providing clinicians with a fast, non-invasive way to detect subtle heart changes before symptoms appear.

MyoStrain offers critical insights that inform proactive decision-making in cardiac care.Let’s transform how we manage t...
09/15/2025

MyoStrain offers critical insights that inform proactive decision-making in cardiac care.

Let’s transform how we manage treatment to mitigate risk and prevent heart failure. Join us in redefining patient care for long-term health benefits.
Learn more: https://bit.ly/4fJsXM2

Waiting for answers shouldn't be part of the journey to heart health. MyoStress® delivers rapid detection and accurate r...
09/10/2025

Waiting for answers shouldn't be part of the journey to heart health. MyoStress® delivers rapid detection and accurate risk assessment for coronary artery disease suspects in just 15 minutes. No pharmacological stressors, no radiation – just efficient, individualized care.
Learn more here: https://bit.ly/45FQzg2

Traditional heart metrics only scratch the surface of heart function, leaving physicians in the dark about the true impa...
09/08/2025

Traditional heart metrics only scratch the surface of heart function, leaving physicians in the dark about the true impact of acute heart failure meds: https://bit.ly/3VcrNPG

MyoStrain® changes the game, offering precision and insight to guide personalized treatment strategies. Let's optimize care, reduce rehospitalizations, and enhance lives. Learn more here: https://bit.ly/4ncUng7

An AHA study on the cardiotoxicity of anthracycline with and without immune checkpoint inhibitor (ICI) in treating high-...
09/03/2025

An AHA study on the cardiotoxicity of anthracycline with and without immune checkpoint inhibitor (ICI) in treating high-risk early-stage triple negative breast cancer (TNBC) patients highlights encouraging results: no significant differences in cardiac events between the two groups. This opens doors for greater confidence in using ICIs in cancer care.

At Myocardial Solutions, we believe advanced imaging tools like MyoStrain® can play a crucial role in studies like this and in clinical practice. MyoStrain® offers early, non-invasive detection of subclinical cardiac dysfunction, helping physicians monitor heart health and guide treatment decisions for patients undergoing aggressive therapies: https://bit.ly/41iLnxo

For high-risk TNBC patients, precision tools like MyoStrain® can help ensure comprehensive care that prioritizes both cancer treatment and heart health.
Let’s continue the conversation on advancing cardio-oncology care.

Address

808 Aviation Pkwy
Morrisville, NC
27560

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+19196778100

Alerts

Be the first to know and let us send you an email when MyoStrain posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to MyoStrain:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram